Gilead Sciences
GILD
GILD
1,597 hedge funds and large institutions have $59.1B invested in Gilead Sciences in 2022 Q1 according to their latest regulatory filings, with 144 funds opening new positions, 697 increasing their positions, 561 reducing their positions, and 208 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 1,679 → 1,597 (-82)
19% less capital invested
Capital invested by funds: $73.3B → $59.1B (-$14.2B)
31% less first-time investments, than exits
New positions opened: 144 | Existing positions closed: 208
Holders
1,597
Holding in Top 10
24
Calls
$1.38B
Puts
$1.22B
Top Buyers
| 1 | +$880M | |
| 2 | +$436M | |
| 3 | +$410M | |
| 4 |
D.E. Shaw & Co
New York
|
+$285M |
| 5 |
Millennium Management
New York
|
+$232M |
Top Sellers
| 1 | -$3.27B | |
| 2 | -$1.94B | |
| 3 | -$264M | |
| 4 |
Barclays
London,
United Kingdom
|
-$156M |
| 5 |
Morgan Stanley
New York
|
-$136M |